1.
Morgan MR. Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism. stlr [Internet]. 2009 Nov. 3 [cited 2024 Apr. 12];11. Available from: https://journals.library.columbia.edu/index.php/stlr/article/view/3846